Newsmeme!
Discover News you didn't know existed
NEW YORK (AP) _ Shares of Williams-Sonoma Inc., which sells high-end kitchenware and home decor, jumped more than 21 percent on Tuesday after a Cowen and Co. analyst said the shares are a value at their current price but risks still loom as discounters gain market share.
(AP:SOUTH SAN FRANCISCO, Calif.) Biotechnology company Theravance Inc. said Tuesday its developing asthma drug improved lung function in a midstage study.
(AP:NEW YORK) Shares of Anadys Pharmaceuticals Inc. rose Tuesday after the biotechnology company said the Food and Drug Administration will give its developing chronic hepatitis C drug a fast-track review.
AUGUSTA, Maine — The three-way race for one of the state’s most prominent public offices, attorney general, will be decided Tuesday as the newly elected Legislature chooses a nominee to head the $30 million department that represents the state in legal matters.
Allos Therapeutics, Inc. (Nasdaq:ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to the Company's novel antifolate, pralatrexate (PDX), for the treatment of patients with follicular lymphoma.
Vancouver, BC, December 2, 2008--(T-Net)--Allon Therapeutics Inc. (TSX:NPC) announced today that patient enrolment is complete in a Phase II clinical trial evaluating the safety and efficacy of the Company's proprietary drug candidate AL-108 in patients with schizophrenia-related cognitive impairment.
( WeissComm Partners ) Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT 501, met all primary endpoints. HZT 501, a novel, proprietary fixed-dose combination product containing ibuprofen and famotidine, demonstrated a statistically significant reduction in the ...
In nominating Eric H. Holder Jr. and Janet Napolitano, Barack Obama selected two Dems with sterling law-and-order credentials but less experience in detecting threats and gathering intelligence in the age of terrorism, reports the Washington Post.
(AP:NEW YORK) Shares of XenoPort Inc. plunged Tuesday after the biotechnology company said its heartburn drug candidate failed to improve severe heartburn symptoms in a midstage study.
Protalix BioTherapeutics, Inc. (Amex: PLX), announced today that it has completed enrollment in the Company’s pivotal phase III clinical trial of prGCD, a proprietary plant cell expressed recombinant form of human glucocerebrosidase (GCD) for the treatment of Gaucher disease. Gaucher disease is a rare and serious lysosomal storage disorder in humans.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |